Department of Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
PLoS One. 2012;7(7):e40162. doi: 10.1371/journal.pone.0040162. Epub 2012 Jul 10.
Carcinoma of gallbladder (GBC) is an aggressive malignancy. The higher incidence of gallbladder cancer in women has been partly attributed to hormonal factors. Therefore the present study was designed to explore the role of genetic variants in estrogen (ESR1, ESR2) and progesterone (PGR) receptors in conferring risk of gallbladder cancer.
The present case-control study recruited total of 860 subjects, including 410 GBC patients, 230 gallstone patients and 220 controls. We examined the associations of 6 selected polymorphisms in three genes: ESR1 (rs2234693, rs9340799, rs1801132), ESR2 (rs1271572, rs1256049) and PGR (rs1042838) with GBC risk. Genotyping for all the polymorphisms was done using PCR-RFLP. Multifactor dimensionality reduction and classification and regression tree approaches were combined with logistic regression to discover high-order gene-gene interactions in hormonal pathway.
On comparing the genotype frequency distribution in gallstone and GBC patients with that of healthy subjects, the homozygous variant genotypes of ESR1-397TT (rs2234693) polymorphism showed significant risk for developing gallstone [odds ratio: OR = 2.9] and GBC [OR = 1.8] respectively. Detailed haplotypes analysis suggested that ESR1 T( rs2234693)G( rs9340799)C( rs1801132) have significant association in conferring risk for both gallstones [OR = 2.2] and GBC [OR = 3.0]. However, the variant-containing genotypes (DI+II) of PGR (rs1042838) showed low risk in both GBC [OR = 0.4] and gallstone patients [OR = 0.4].On performing the MDR analysis, ESR1 IVS1-397C>T, ESR1 IVS1-351A>G, and ESR2-789 A>C yielded the highest testing accuracy of 0.634. These results were further supported by the CART analysis which revealed that individuals with the combined genotypes of ESR1-397 CT or TT, ESR1-351 AG or GG and ESR2 -789 AA had the highest risk for GBC [OR = 3.9].
Using multi-analytical approaches, our study showed important role of ESR1 IVS1-397C>T, ESR1 IVS1-351A>G, and ESR2-789 A>C variants in GBC susceptibility and the risk appears to be mediated through gallstone dependent pathway.
胆囊癌(GBC)是一种侵袭性恶性肿瘤。女性胆囊癌发病率较高部分归因于激素因素。因此,本研究旨在探讨雌激素(ESR1、ESR2)和孕激素(PGR)受体基因中的遗传变异在赋予胆囊癌风险中的作用。
本病例对照研究共招募了 860 名受试者,包括 410 名 GBC 患者、230 名胆结石患者和 220 名对照。我们研究了三个基因中 6 个选定的多态性与 GBC 风险的关联:ESR1(rs2234693、rs9340799、rs1801132)、ESR2(rs1271572、rs1256049)和 PGR(rs1042838)。所有多态性的基因分型均采用 PCR-RFLP 法进行。多因子维度缩减和分类回归树方法与逻辑回归相结合,用于发现激素途径中的高阶基因-基因相互作用。
在比较胆结石和 GBC 患者与健康受试者的基因型频率分布时,ESR1-397TT(rs2234693)纯合变体基因型显示出胆结石[比值比(OR)=2.9]和 GBC[OR=1.8]发展的显著风险。详细的单倍型分析表明,ESR1 T(rs2234693)G(rs9340799)C(rs1801132)在胆结石[OR=2.2]和 GBC[OR=3.0]的发病风险中具有显著相关性。然而,PGR(rs1042838)的变异基因型(DI+II)在 GBC[OR=0.4]和胆结石患者[OR=0.4]中显示出低风险。进行 MDR 分析时,ESR1 IVS1-397C>T、ESR1 IVS1-351A>G 和 ESR2-789 A>C 产生了最高的检测准确率为 0.634。CART 分析进一步支持了这些结果,该分析显示,ESR1-397 CT 或 TT、ESR1-351 AG 或 GG 和 ESR2-789 AA 联合基因型的个体患 GBC 的风险最高[OR=3.9]。
使用多分析方法,本研究表明 ESR1 IVS1-397C>T、ESR1 IVS1-351A>G 和 ESR2-789 A>C 变体在 GBC 易感性中起重要作用,并且风险似乎通过胆结石相关途径介导。